The fair value estimate for Ionis Pharmaceuticals has shifted from US$96.73 to US$100.92, a modest reset that puts fresh numbers around the stock. This move comes during an active period of Street ...
This is a new position for Capricorn Fund Managers Ltd, representing 3.58% of 13F reportable AUM as of September 30, 2025. Top holdings after the filing: WAY: $19.15 million (6.4% of AUM) as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results